Additionally, chromatin immunoprecipitation (ChIP) assays (Figure 6G) showed that combination treatment significantly decreased RELA/NF-κB occupancy at the NRF2 promoter in HCC cells, particularly at the kB2 site (Figures 6H,I), providing direct evidence of transcriptional regulation. Here, NFE2L2 is linked to hepatocellular carcinoma.